UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The Value of Brachytherapy for Intermediate-Risk Localized Prostate Cancer Using Ichom Outcomes and Time-Driven Activity-Based Costing: Results From a Phase 2 Prospective Trial of 300 Patients

International journal of radiation oncology, biology, physics, 2016-10, Vol.96 (2), p.E400-E401

2016

Volltextzugriff (PDF)

Quality Improvement in Prostate Brachytherapy Using Time Driven Activity Based Costing

International journal of radiation oncology, biology, physics, 2015-11, Vol.93 (3), p.E503-E503

2015

Volltextzugriff (PDF)

Structure and function of mitochondrial anion transport proteins

The Journal of membrane biology, 2001-02, Vol.179 (3), p.165-183

Kaplan, R S

2001

Volltextzugriff (PDF)

Which prostate cancers are overlooked by mpMRI? An analysis from PROMIS

European urology open science (Online), 2020-07, Vol.19, p.e465-e466

2020

Volltextzugriff (PDF)

794P UK practices for treatment of relapse in seminoma testicular cancer

Annals of oncology, 2020-09, Vol.31, p.S603-S603

2020

Volltextzugriff (PDF)

714P Prognostic factors in stage I seminoma: Data from the phase III, randomised TRial of Imaging and Surveillance in Seminoma Testis (TRISST)

Annals of oncology, 2021-09, Vol.32, p.S720-S720

2021

Volltextzugriff (PDF)

337P Prediction of poor response to oxaliplatin by an RNA signature derived and validated in colorectal cancer clinical trials

Annals of oncology, 2022-09, Vol.33, p.S691

2022

Volltextzugriff (PDF)

431P The FOCUS4-N trial results and individual patient data meta-analysis (IPDM) of maintenance therapy versus active monitoring for patients with metastatic colorectal cancer (mCRC)

Annals of oncology, 2021-09, Vol.32, p.S549-S549

2021

Volltextzugriff (PDF)

Are cost advantages from a modern Indian hospital transferable to the United States?

The American heart journal, 2020-06, Vol.224, p.148-155

2020

Volltextzugriff (PDF)

432P Toxicity and efficacy of 1st line cetuximab (cetux)-based therapy in RAS wildtype (WT) older patients (pts) with metastatic colorectal cancer (mCRC): A pooled analysis from 1,274 pts in the ARCAD database

Annals of oncology, 2020-09, Vol.31, p.S425-S425

2020

Volltextzugriff (PDF)

LBA56 - Primary efficacy analysis results from the SORCE trial (RE05): Adjuvant sorafenib for renal cell carcinoma at intermediate or high risk of relapse: An international, randomised double-blind phase III trial led by the MRC CTU at UCL

Annals of oncology, 2019-10, Vol.30, p.v891-v892

2019

Volltextzugriff (PDF)

Primary efficacy analysis results from the SORCE trial (RE05): Adjuvant sorafenib for renal cell carcinoma at intermediate or high risk of relapse: An international, randomised double-blind phase III trial led by the MRC CTU at UCL

Annals of oncology, 2019-10, Vol.30, p.v891-v892

2019

Volltextzugriff (PDF)

How to implement a new strategy without disrupting your organization

HARVARD BUSINESS REVIEW, 2006-03, Vol.22 (8)

Kaplan, R.S.

2006

Volltextzugriff (PDF)

805O ICON8: Overall survival results in a GCIG phase III randomised controlled trial of weekly dose-dense chemotherapy in first line epithelial ovarian, fallopian tube or primary peritoneal carcinoma treatment

Annals of oncology, 2020-09, Vol.31, p.S610-S610

2020

Volltextzugriff (PDF)

Common and rare DPYD variants are predictive for 5FU/capecitabine (5FU) toxicity: The MRC COIN and COIN-B trials

Annals of oncology, 2018-10, Vol.29, p.viii22-viii22

2018

Volltextzugriff (PDF)

Response to neoadjuvant chemotherapy in ICON8: A GCIG phase III randomised trial evaluating weekly dose-dense chemotherapy integration in first-line epithelial ovarian/ fallopian tube/ primary peritoneal carcinoma (EOC) treatment

Annals of oncology, 2018-10, Vol.29, p.viii336-viii336

2018

Volltextzugriff (PDF)

Cediranib in addition to chemotherapy for women with relapsed platinum-sensitive ovarian cancer (ICON6): overall survival results of a phase III randomised trial

ESMO open, 2021-04, Vol.6 (2), p.100043-100043, Article 100043

2021

Volltextzugriff (PDF)

What to ask the person in the mirror (leadership and career development)

Development and learning in organizations, 2007-07, Vol.21 (4)

Kaplan, R.S.

2007

Volltextzugriff (PDF)

Response to S. Voelpel et al., The tyranny of the Balanced Scorecard in the innovation economy, Journal of Intellectual Capital, Vol. 7 No. 1, 2006, pp. 4360

Journal of intellectual capital, 2006-07, Vol.7 (3), p.421-428

2006

Volltextzugriff (PDF)

Response to S. Voelpel et al., "The tyranny of the Balanced Scorecard in the innovation economy," Journal of Intellectual Capital, Vol. 7 No. 1, 2006, pp. 43-60

Journal of intellectual capital, 2006-07, Vol.7 (3), p.421-428

2006

Volltextzugriff (PDF)

High level expression and characterization of the mitochondrial citrate transport protein from the yeast Saccharomyces cerevisiae

The Journal of biological chemistry, 1995-02, Vol.270 (8), p.4108-4114

1995

Volltextzugriff (PDF)

The mitochondrial tricarboxylate transport protein. cDNA cloning, primary structure, and comparison with other mitochondrial transport proteins

The Journal of biological chemistry, 1993-06, Vol.268 (18), p.13682-13690

1993

Volltextzugriff (PDF)

Identification of a Novel Gene Encoding the Yeast Mitochondrial Dicarboxylate Transport Protein via Overexpression, Purification, and Characterization of Its Protein Product

The Journal of biological chemistry, 1997-02, Vol.272 (7), p.4516-4521

1997

Volltextzugriff (PDF)

yeast mitochrondrial citrate transport protein. Probing the secondary structure of transmembrane domain IV and identification of residues that likely comprise a portion of the citrate translocation pathway

The Journal of biological chemistry, 2000, Vol.275 (16), p.12009-12016

2000

Volltextzugriff (PDF)

yeast mitochondrial citrate transport protein: probing the roles of cysteines, Arg181, and Arg189 in transporter function

The Journal of biological chemistry, 2000, Vol.275 (10), p.7117-7124

2000

Volltextzugriff (PDF)

1 – 25 von 112

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(93)
Mit Volltextzugriff
(102)

Publikationsform

Sprache

Englisch
(112)

Erscheinungsjahr

n.n

Thema

Science & Technology
(47)
Life Sciences & Biomedicine
(28)
Humans
(20)
Technology
(13)
Male
(12)
Animals
(11)
Biological And Medical Sciences
(11)
Biochemistry & Molecular Biology
(10)
Engineering
(10)
Engineering, Electrical & Electronic
(9)
Imaging Phantoms
(9)
Physical Sciences
(9)
Physics
(8)
Testing
(8)
Adult
(7)
Female
(7)
Biophysics
(6)
Carrier Proteins - Metabolism
(6)
Fundamental And Applied Biological Sciences. Psychology
(6)
Kinetics
(6)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

The Value of Brachytherapy for Intermediate-Risk Localized Prostate Cancer Using Ichom Outcomes and Time-Driven Activity-Based Costing: Results From a Phase 2 Prospective Trial of 300 Patients

Quality Improvement in Prostate Brachytherapy Using Time Driven Activity Based Costing

Structure and function of mitochondrial anion transport proteins

Which prostate cancers are overlooked by mpMRI? An analysis from PROMIS

794P UK practices for treatment of relapse in seminoma testicular cancer

714P Prognostic factors in stage I seminoma: Data from the phase III, randomised TRial of Imaging and Surveillance in Seminoma Testis (TRISST)

337P Prediction of poor response to oxaliplatin by an RNA signature derived and validated in colorectal cancer clinical trials

431P The FOCUS4-N trial results and individual patient data meta-analysis (IPDM) of maintenance therapy versus active monitoring for patients with metastatic colorectal cancer (mCRC)

Are cost advantages from a modern Indian hospital transferable to the United States?

432P Toxicity and efficacy of 1st line cetuximab (cetux)-based therapy in RAS wildtype (WT) older patients (pts) with metastatic colorectal cancer (mCRC): A pooled analysis from 1,274 pts in the ARCAD database

LBA56 - Primary efficacy analysis results from the SORCE trial (RE05): Adjuvant sorafenib for renal cell carcinoma at intermediate or high risk of relapse: An international, randomised double-blind phase III trial led by the MRC CTU at UCL

Primary efficacy analysis results from the SORCE trial (RE05): Adjuvant sorafenib for renal cell carcinoma at intermediate or high risk of relapse: An international, randomised double-blind phase III trial led by the MRC CTU at UCL

How to implement a new strategy without disrupting your organization

805O ICON8: Overall survival results in a GCIG phase III randomised controlled trial of weekly dose-dense chemotherapy in first line epithelial ovarian, fallopian tube or primary peritoneal carcinoma treatment

Common and rare DPYD variants are predictive for 5FU/capecitabine (5FU) toxicity: The MRC COIN and COIN-B trials

Response to neoadjuvant chemotherapy in ICON8: A GCIG phase III randomised trial evaluating weekly dose-dense chemotherapy integration in first-line epithelial ovarian/ fallopian tube/ primary peritoneal carcinoma (EOC) treatment

Cediranib in addition to chemotherapy for women with relapsed platinum-sensitive ovarian cancer (ICON6): overall survival results of a phase III randomised trial

What to ask the person in the mirror (leadership and career development)

Response to S. Voelpel et al., The tyranny of the Balanced Scorecard in the innovation economy, Journal of Intellectual Capital, Vol. 7 No. 1, 2006, pp. 4360

Response to S. Voelpel et al., "The tyranny of the Balanced Scorecard in the innovation economy," Journal of Intellectual Capital, Vol. 7 No. 1, 2006, pp. 43-60

High level expression and characterization of the mitochondrial citrate transport protein from the yeast Saccharomyces cerevisiae

The mitochondrial tricarboxylate transport protein. cDNA cloning, primary structure, and comparison with other mitochondrial transport proteins

Identification of a Novel Gene Encoding the Yeast Mitochondrial Dicarboxylate Transport Protein via Overexpression, Purification, and Characterization of Its Protein Product

yeast mitochrondrial citrate transport protein. Probing the secondary structure of transmembrane domain IV and identification of residues that likely comprise a portion of the citrate translocation pathway

yeast mitochondrial citrate transport protein: probing the roles of cysteines, Arg181, and Arg189 in transporter function

Suchergebnisse filtern